Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Mild cognitive impairment and kidney disease: clinical aspects.

Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutiérrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauß S, König M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlík I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G.

Nephrol Dial Transplant. 2019 Apr 9. pii: gfz051. doi: 10.1093/ndt/gfz051. [Epub ahead of print] No abstract available.

PMID:
31071220
2.

PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited.

Knauss S, Preusse C, Allenbach Y, Leonard-Louis S, Touat M, Fischer N, Radbruch H, Mothes R, Matyash V, Böhmerle W, Endres M, Goebel HH, Benveniste O, Stenzel W.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 10;6(3):e558. doi: 10.1212/NXI.0000000000000558. eCollection 2019 May.

3.

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.

Weston M, Kaserer T, Wu A, Mouravlev A, Carpenter JC, Snowball A, Knauss S, von Schimmelmann M, During MJ, Lignani G, Schorge S, Young D, Kullmann DM, Lieb A.

Sci Adv. 2019 Apr 17;5(4):eaaw1567. doi: 10.1126/sciadv.aaw1567. eCollection 2019 Apr.

4.

A Mobile Health Wallet for Pregnancy-Related Health Care in Madagascar: Mixed-Methods Study on Opportunities and Challenges.

Muller N, Emmrich PMF, Rajemison EN, De Neve JW, Bärnighausen T, Knauss S, Emmrich JV.

JMIR Mhealth Uhealth. 2019 Mar 5;7(3):e11420. doi: 10.2196/11420.

5.

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors.

Moreira A, Loquai C, Pföhler C, Kähler KC, Knauss S, Heppt MV, Gutzmer R, Dimitriou F, Meier F, Mitzel-Rink H, Schuler G, Terheyden P, Thoms KM, Türk M, Dummer R, Zimmer L, Schröder R, Heinzerling L.

Eur J Cancer. 2019 Jan;106:12-23. doi: 10.1016/j.ejca.2018.09.033. Epub 2018 Nov 17.

PMID:
30453170
6.

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer.

Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Auré K, Szwebel TA, Kramkimel N, Lethrosne C, Bruch JF, Laly P, Cadranel J, Weiss N, Béhin A, Allenbach Y, Benveniste O, Lenglet T, Psimaras D, Stenzel W, Léonard-Louis S.

Neurology. 2018 Sep 4;91(10):e985-e994. doi: 10.1212/WNL.0000000000006124. Epub 2018 Aug 8.

PMID:
30089619
7.

[Neurological side effects of checkpoint inhibitors].

Knauss S, Ginesta Roque L, Hühnchen P, Heinzerling L, Böhmerle W, Endres M.

Nervenarzt. 2019 Feb;90(2):138-147. doi: 10.1007/s00115-018-0571-8. Review. German.

PMID:
30073487
8.

[Nationwide survey of postgraduate medical training in clinical neurology].

Biesalski AS, Franke C, Sturm D, Behncke J, Schreckenbach T, Knauß S, Eisenberg H, Hillienhof A, Sand F, Zupanic M.

Nervenarzt. 2018 Dec;89(12):1378-1387. doi: 10.1007/s00115-018-0547-8. German.

PMID:
29872878
9.

Oral administration of a novel lipophilic PPARδ agonist is not neuroprotective after rodent cerebral ischemia.

Knauss S, Endres M, Blaschke F, Hindinger C, Kunz A.

J Cereb Blood Flow Metab. 2018 Jan;38(1):174-185. doi: 10.1177/0271678X17743876. Epub 2017 Nov 21.

10.

From aneuploidy to cancer: the evolution of a new species?

Knauss S, Klein A.

J Biosci. 2012 Jun;37(2):211-20. No abstract available.

PMID:
22581326
11.

The auxin-induced maize gene ZmSAUR2 encodes a short-lived nuclear protein expressed in elongating tissues.

Knauss S, Rohrmeier T, Lehle L.

J Biol Chem. 2003 Jun 27;278(26):23936-43. Epub 2003 Apr 14.

12.

Risk factors for higher cost in congenital heart operations.

Ungerleider RM, Bengur AR, Kessenich AL, Liekweg RJ, Hart EM, Rice BA, Miller CE, Lockwood NW, Knauss SA, Jaggers J, Sanders SP, Greeley WJ.

Ann Thorac Surg. 1997 Jul;64(1):44-8; discussion 49.

PMID:
9236333

Supplemental Content

Loading ...
Support Center